Diabetes: FDA Puts Highest-Risk Status on J&J's Animas Insulin Pump Recall

Fri, 04/05/2013 - 12:01pm
Mass Device

The FDA warns that Johnson & Johnson subsidiary Animas Corp.'s recalled insulin pumps "may cause serious adverse health consequences, including death."

Animas Corp. logo

The FDA put its highest-risk category on Johnson & Johnson (NYSE:JNJ) subsidiary Animas Corp.'s insulin pump recall over concerns that the devices may cause patient harm or even death.

Certain pumps were recalled over concerns that a "component" issue could trigger a false alarm or a sudden warning requiring that the patient rewind, load and prime the device.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.